Engineered bacteria show promise in cancer treatment

Scientists are reviving a century-old cancer treatment using genetically engineered bacteria to target and destroy cancer cells. This approach, which dates back to the 1860s, is gaining traction as modern research validates its potential. Recent advances in synthetic biology allow researchers to program bacteria to deliver anti-cancer agents directly within tumors. This targeted method may improve treatment for solid tumors that resist conventional therapies, such as colon and ovarian cancers. Emerging studies show promising results, with engineered bacteria helping the immune system recognize and attack cancer cells. While human trials are needed, the progress in bacteria-based therapies suggests a new direction in cancer treatment.